Gastric atrophy and oesophageal squamous cell carcinoma: Possible interaction with dental health and oral hygiene habit

British Journal of Cancer

Volumn 107, Issue 5, 2012, Pages 888-894

  Nasrollahzadeh, D ^a,b   Malekzadeh, R ^a,b   Aghcheli, K ^b   Sotoudeh, M ^b   Merat, S ^b   Islami, F ^b,c   Kamangar, F ^b,d   Abnet, C C ^e   Shakeri, R ^b   Pourshams, A ^b   Semnani, S ^f   Boffetta, P ^c   Dawsey, S M ^e   Ye, W ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d MORGAN STATE UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

atrophic gastritis; dental health; oesophageal neoplasm; oral hygiene; pepsinogen; relative risk

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DENTAL CARIES; DENTAL HEALTH; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GASTRITIS; HABIT; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH ATROPHY; TOOTH FILLING;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GASTRITIS, ATROPHIC; HUMANS; MALE; MIDDLE AGED; ORAL HYGIENE; PEPSINOGEN A; PEPSINOGEN C; QUESTIONNAIRES; RISK FACTORS;

EID: 84865444305     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.332     Document Type: Article

References (31)

1. Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, Merat S, Pourshams A, Marjani HA, Ebadati A, Sotoudeh M, Boffetta P, Malekzadeh R, Dawsey SM (2008) Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17(11): 3062-3068
2. Abnet CC, Qiao YL, Mark SD, Dong ZW, Taylor PR, Dawsey SM (2001) Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes Control 12(9): 847-854 (Pubitemid 33010623)
3. Abnet CC, Zheng W, Ye W, Kamangar F, Ji BT, Persson C, Yang G, Li HL, Rothman N, Shu XO, Gao YT, Chow WH (2011) Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort. Br J Cancer 104(9): 1511-1516
4. Abraham SC, Yardley JH, Wu TT (1999) Erosive injury to the upper gastrointestinal tract in patients receiving iron medication: an under-recognized entity. Am J Surg Pathol 23(10): 1241-1247 (Pubitemid 29474594)
5. Adamu MA, Weck MN, Rothenbacher D, Brenner H (2011) Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study. Int J Cancer 128(7): 1652-1658
6. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA (2006) Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 103(3): 732-737 (Pubitemid 43153094)
7. Cook MB, Dawsey SM, Diaw L, Blaser MJ, Perez-Perez GI, Abnet CC, Taylor PR, Albanes D, Virtamo J, Kamangar F (2010) Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 19(8): 1966-1975
8. de Vries AC, Capelle LG, Looman CW, van Blankenstein M, van Grieken NC, Casparie MK, Meijer GA, Kuipers EJ (2009) Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: independent of the severity of atrophic changes. Int J Cancer 124(9): 2135-2138
9. He CY, Sun LP, Gong YH, Xu Q, Dong NN, Yuan Y (2011) Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs. J Gastroenterol Hepatol 26(6): 1039-1046
10. Iijima K, Koike T, Abe Y, Inomata Y, Sekine H, Imatani A, Nakaya N, Ohara S, Shimosegawa T (2007) Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol 102(8): 1603-1609 (Pubitemid 47206685)
11. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, Abedi-Ardekani B, Merat S, Vahedi H, Semnani S, Abnet CC, Brennan P, Moller H, Saidi F, Dawsey SM, Malekzadeh R, Boffetta P (2009) Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 338: b929
12. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2): 69-90
13. Kamangar F, Qiao YL, Blaser MJ, Sun XD, Katki H, Fan JH, Perez-Perez GI, Abnet CC, Zhao P, Mark SD, Taylor PR, Dawsey SM (2007) Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 96(1): 172-176 (Pubitemid 46094658)
14. Lauwers GY, Fujita H, Nagata K, Shimizu M (2010) Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons. J Gastroenterol 45(2): 131-145
15. Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S (1973) Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer 28(3): 197-214
16. Malekshah AF, Kimiagar M, Saadatian-Elahi M, Pourshams A, Nouraie M, Goglani G, Hoshiarrad A, Sadatsafavi M, Golestan B, Yoonesi A, Rakhshani N, Fahimi S, Nasrollahzadeh D, Salahi R, Ghafarpour A, Semnani S, Steghens JP, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R (2006) Validity and reliability of a new food frequency questionnaire compared to 24h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr 60(8): 971-977 (Pubitemid 44161018)
17. Meurman JH, Bascones-Martinez A (2011) Are oral and dental diseases linked to cancer? Oral Dis 17(8): 779-784
18. Meurman JH, Uittamo J (2008) Oral micro-organisms in the etiology of cancer. Acta Odontol Scand 66(6): 321-326
19. Millonig G, Wang Y, Homann N, Bernhardt F, Qin H, Mueller S, Bartsch H, Seitz HK (2011) Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions. Int J Cancer 128(3): 533-540
20. Nair J, Ohshima H, Nair UJ, Bartsch H (1996) Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Crit Rev Toxicol 26(2): 149-161 (Pubitemid 26111895)
21. Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Shakeri R, Persson EC, Islami F, Kamangar F, Abnet CC, Boffetta P, Engstrand L, Dawsey SM, Malekzadeh R, Ye W (2011) Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. Plos One 6(10): e26957
22. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, Shakeri R, Pourshams A, Marjani HA, Nouraie M, Khatibian M, Semnani S, Ye W, Boffetta P, Dawsey SM, Malekzadeh R (2008) Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 98(11): 1857-1863 (Pubitemid 351748837)
23. National Toxicology Program (2010) Final report on carcinogens background document for formaldehyde. Rep Carcinog Backgr Doc (10-5981): i-512
24. Owen DA (2003) Gastritis and carditis. Mod Pathol 16(4): 325-341 (Pubitemid 36443982)
25. Pourshams A, Saadatian-Elahi M, Nouraie M, Malekshah AF, Rakhshani N, Salahi R, Yoonessi A, Semnani S, Islami F, Sotoudeh M, Fahimi S, Sadjadi AR, Nasrollahzadeh D, Aghcheli K, Kamangar F, Abnet CC, Saidi F, Sewram V, Strickland PT, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R (2005) Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer 92(1): 176-181 (Pubitemid 40188452)
26. Ren JS, Kamangar F, Qiao YL, Taylor PR, Liang H, Dawsey SM, Liu B, Fan JH, Abnet CC (2009) Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort. Gut 58(5): 636-642
27. Saidi F, Sepehr A, Fahimi S, Farahvash MJ, Salehian P, Esmailzadeh A, Keshoofy M, Pirmoazen N, Yazdanbod M, Roshan MK (2000) Oesophageal cancer among the Turkomans of northeast Iran. Br J Cancer 83(9): 1249-1254
28. Venerito M, Kohrs S, Wex T, Adolf D, Kuester D, Schubert D, Peitz U, Monkemuller K, Malfertheiner P (2011) Helicobacter pylori infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma: a case-control study. Eur J Gastroenterol Hepatol 23(10): 859-864
29. Viani F, Siegrist HH, Pignatelli B, Cederberg C, Idstrom JP, Verdu EF, Fried M, Blum AL, Armstrong D (2000) The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach. Eur J Gastroenterol Hepatol 12(2): 165-173 (Pubitemid 30166681)
30. Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyren O (2004) Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 96(5): 388-396 (Pubitemid 38351300)
31. Yokoyama A, Omori T, Yokoyama T, Kawakubo H, Mori S, Matsui T, Maruyama K (2009) Chronic atrophic gastritis and metachronous gastric cancer in Japanese alcoholic men with oesophageal squamous cell carcinoma. Alcohol Clin Exp Res 33(5): 898-905